Search research articles
Contact Us
Filters
Showing results (171-180 of 525) with videos related to
Page
of 53
Sort By:
Urology Case Reports
|
February 2, 2019
PSMA-targeted [<sup>18</sup>F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework
Diane K Reyes, Shadpour Demehri, Rudolf A Werner, et al.
Molecular Imaging and Biology
|
July 13, 2018
SPECT/CT Imaging of Mycobacterium tuberculosis Infection with [<sup>125</sup>I]anti-C3d mAb
Catherine A Foss, Liudmila Kulik, Alvaro A Ordonez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
Babak Behnam Azad, Ala Lisok, Samit Chatterjee, et al.
PET Clinics
|
October 13, 2022
<sup>18</sup>F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future Directions
Steven P Rowe, Ali Salavati, Rudolf A Werner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 31, 2019
The next era of renal radionuclide imaging: novel PET radiotracers
Rudolf A Werner, Xinyu Chen, Constantin Lapa, et al.
Seminars in Nuclear Medicine
|
June 23, 2019
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
Sara Sheikhbahaei, Rudolf A Werner, Lilja B Solnes, et al.
Molecular Imaging
|
April 21, 2007
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer
Catherine A Foss, James J Fox, Georg Feldmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 8, 2018
Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories
Yafu Yin, Rudolf A Werner, Takahiro Higuchi, et al.
Advances in Cancer Research
|
September 11, 2016
Detecting Tumor Metastases: The Road to Therapy Starts Here
M E Menezes, S K Das, I Minn, et al.
Molecular Pharmaceutics
|
August 18, 2020
Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy
Colin T Huang, Xin Guo, Cyril Bařinka, et al.
Page
of 53
Search research articles
Search
Showing results (171-180 of 525) with videos related to
Sort By:
Page
of 53
Urology Case Reports
|
February 2, 2019
PSMA-targeted [<sup>18</sup>F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework
Diane K Reyes, Shadpour Demehri, Rudolf A Werner, et al.
Molecular Imaging and Biology
|
July 13, 2018
SPECT/CT Imaging of Mycobacterium tuberculosis Infection with [<sup>125</sup>I]anti-C3d mAb
Catherine A Foss, Liudmila Kulik, Alvaro A Ordonez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
Babak Behnam Azad, Ala Lisok, Samit Chatterjee, et al.
PET Clinics
|
October 13, 2022
<sup>18</sup>F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future Directions
Steven P Rowe, Ali Salavati, Rudolf A Werner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 31, 2019
The next era of renal radionuclide imaging: novel PET radiotracers
Rudolf A Werner, Xinyu Chen, Constantin Lapa, et al.
Seminars in Nuclear Medicine
|
June 23, 2019
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
Sara Sheikhbahaei, Rudolf A Werner, Lilja B Solnes, et al.
Molecular Imaging
|
April 21, 2007
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer
Catherine A Foss, James J Fox, Georg Feldmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 8, 2018
Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories
Yafu Yin, Rudolf A Werner, Takahiro Higuchi, et al.
Advances in Cancer Research
|
September 11, 2016
Detecting Tumor Metastases: The Road to Therapy Starts Here
M E Menezes, S K Das, I Minn, et al.
Molecular Pharmaceutics
|
August 18, 2020
Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy
Colin T Huang, Xin Guo, Cyril Bařinka, et al.
Page
of 53